BR0015477A - Soluções contendo epinastina - Google Patents

Soluções contendo epinastina

Info

Publication number
BR0015477A
BR0015477A BR0015477-6A BR0015477A BR0015477A BR 0015477 A BR0015477 A BR 0015477A BR 0015477 A BR0015477 A BR 0015477A BR 0015477 A BR0015477 A BR 0015477A
Authority
BR
Brazil
Prior art keywords
solutions containing
containing epinastine
optionally
epinastine
racemate
Prior art date
Application number
BR0015477-6A
Other languages
English (en)
Inventor
Volker Trach
Gerold Duchler
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7928843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0015477(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of BR0015477A publication Critical patent/BR0015477A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F01—MACHINES OR ENGINES IN GENERAL; ENGINE PLANTS IN GENERAL; STEAM ENGINES
    • F01L—CYCLICALLY OPERATING VALVES FOR MACHINES OR ENGINES
    • F01L9/00—Valve-gear or valve arrangements actuated non-mechanically
    • F01L9/20—Valve-gear or valve arrangements actuated non-mechanically by electric means
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00—Fluid handling
    • Y10T137/0318—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Detergent Compositions (AREA)

Abstract

"SOLUçõES CONTENDO EPINASTINA". A invenção refere-se a soluções aquosas topicamente aplicáveis contendo epinastina, opcionalmente na forma de seu racemato, seus enanciómeros, assim como opcionalmente na forma de seus sais ácidos de adição farmacologicamente inofensivos.
BR0015477-6A 1999-11-12 2000-10-14 Soluções contendo epinastina BR0015477A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19954516A DE19954516A1 (de) 1999-11-12 1999-11-12 Epinastin-haltige Lösungen
PCT/EP2000/010122 WO2001035962A1 (de) 1999-11-12 2000-10-14 Epinastin-haltige lösungen

Publications (1)

Publication Number Publication Date
BR0015477A true BR0015477A (pt) 2002-06-25

Family

ID=7928843

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0015477-6A BR0015477A (pt) 1999-11-12 2000-10-14 Soluções contendo epinastina

Country Status (40)

Country Link
US (6) US20030050303A1 (pt)
EP (1) EP1231920B1 (pt)
JP (1) JP2003514021A (pt)
KR (1) KR100758842B1 (pt)
CN (1) CN1292752C (pt)
AR (1) AR026424A1 (pt)
AT (1) ATE353218T1 (pt)
AU (2) AU784017B2 (pt)
BG (1) BG65775B1 (pt)
BR (1) BR0015477A (pt)
CA (1) CA2391076C (pt)
CO (1) CO5251448A1 (pt)
CY (1) CY1106375T1 (pt)
CZ (1) CZ302483B6 (pt)
DE (2) DE19954516A1 (pt)
DK (1) DK1231920T3 (pt)
EA (1) EA006937B1 (pt)
EE (1) EE05395B1 (pt)
ES (1) ES2281359T3 (pt)
HK (1) HK1052303B (pt)
HR (1) HRP20020404B1 (pt)
HU (1) HU229502B1 (pt)
IL (2) IL149501A0 (pt)
ME (1) MEP36708A (pt)
MX (1) MXPA02004556A (pt)
MY (1) MY130441A (pt)
NO (1) NO329417B1 (pt)
NZ (1) NZ519425A (pt)
PE (1) PE20010826A1 (pt)
PL (1) PL198879B1 (pt)
PT (1) PT1231920E (pt)
RS (1) RS50173B (pt)
SA (1) SA01210658B1 (pt)
SI (1) SI1231920T1 (pt)
SK (1) SK287343B6 (pt)
TR (1) TR200201270T2 (pt)
TW (1) TWI225401B (pt)
UA (1) UA74563C2 (pt)
WO (1) WO2001035962A1 (pt)
ZA (1) ZA200203683B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
AU2003250073A1 (en) * 2002-08-02 2004-02-25 Boehringer Ingelheim International Gmbh Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
EP1468696A1 (en) * 2003-04-17 2004-10-20 Boehringer Ingelheim International GmbH Combinations of epinastine and antiphlogisitcs as new pharmaceutical compositions for the treatment of skin diseases
US20040247686A1 (en) * 2003-04-04 2004-12-09 Boehringer Ingelheim International Gmbh Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
KR20080034916A (ko) * 2005-07-08 2008-04-22 센주 세이야꾸 가부시키가이샤 에피나스틴을 포함하는 경피 흡수 안과 제제
WO2008098122A2 (en) * 2007-02-08 2008-08-14 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
US7378082B1 (en) 2007-11-05 2008-05-27 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
US20080194544A1 (en) * 2007-02-08 2008-08-14 Ramesh Krishnamoorthy Aqueous formulations of epinastine for treating allergic rhinitis
WO2011019940A2 (en) * 2009-08-12 2011-02-17 Seros Medical, Llc Deuterated water and riboflavin solution for extending singlet oxygen lifetimes in treatment of ocular tissue and method for use
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
EP2630952A1 (en) * 2012-02-23 2013-08-28 Novagali Pharma S.A. Self-preserved oil dispersions comprising boric acid
ES2846724T3 (es) * 2012-12-19 2021-07-29 Novartis Ag Formulaciones de inhibidores de LFA-1
CN104491876A (zh) * 2014-12-23 2015-04-08 中国药科大学 含玻璃酸钠的依匹斯汀滴眼液及其制备方法
ITUB20153950A1 (it) * 2015-09-28 2017-03-28 Tred Srl Dispositivo nasale in grado di attivare il riflesso rino-palatale per l'igienizzazione rinofaringea
JP6134853B1 (ja) * 2016-10-28 2017-05-24 参天製薬株式会社 エピナスチン含有点眼液
JP6635974B2 (ja) * 2017-04-24 2020-01-29 参天製薬株式会社 エピナスチン含有点眼液
TW201841620A (zh) * 2017-05-01 2018-12-01 日商參天製藥股份有限公司 點眼劑
JP2019108320A (ja) * 2018-10-31 2019-07-04 参天製薬株式会社 ソフトコンタクトレンズの変質を抑制する眼科用組成物
JP7599838B2 (ja) * 2019-04-10 2024-12-16 参天製薬株式会社 エピナスチン又はその塩を含有する水性医薬組成物
JP6736752B2 (ja) * 2019-12-17 2020-08-05 参天製薬株式会社 エピナスチン含有点眼液
JP6963651B2 (ja) * 2020-04-16 2021-11-10 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP7118579B1 (ja) 2020-04-16 2022-08-16 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP2020169213A (ja) * 2020-07-15 2020-10-15 参天製薬株式会社 エピナスチン含有点眼液
JP7114668B2 (ja) * 2020-10-08 2022-08-08 参天製薬株式会社 エピナスチン又はその塩を含有する花粉破裂抑制剤
CN115448927A (zh) * 2022-10-20 2022-12-09 重庆瑞泊莱医药科技有限公司 一种氢溴酸依匹斯汀晶型ii及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US151541A (en) * 1874-06-02 Improvement in hay-loaders
US203021A (en) * 1878-04-30 Improvement in side-bar wagons
US181478A (en) * 1876-08-22 Improvement in water-wheels
US215396A (en) * 1879-05-13 Improvement in loom-temples
US104017A (en) * 1870-06-07 Improvement in embroidering attachment for sewing-machines
US228359A (en) * 1880-06-01 jones
US8632A (en) * 1852-01-06 George hess
DE3008944A1 (de) * 1980-03-08 1981-09-24 C.H. Boehringer Sohn, 6507 Ingelheim Dibenzimidazoazepine, ihre herstellung und verwendung
DE4102148A1 (de) * 1991-01-25 1992-07-30 Boehringer Ingelheim Kg Verfahren zur herstellung von 3-amino-9,13b-dihydro-1h-dibenz-(c,f)imidazol(1,5-a)azepin-hydrochlorid
US5668133A (en) * 1992-12-09 1997-09-16 Alcon Laboratories, Inc. Ophthalmic compositions comprising emedastine and methods for their use
PT835098E (pt) * 1995-06-27 2002-12-31 Boehringer Ingelheim Pharma Nova composicao farmaceutica estavel para a producao de aerossois sem gas propulsante
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne
WO1998008504A1 (en) * 1996-08-30 1998-03-05 Kyoto Pharmaceutical Industries, Ltd. Remedies for allergic dermatitis
US20030215396A1 (en) * 1999-09-15 2003-11-20 Boehringer Ingelheim Pharma Kg Method for the production of propellant gas-free aerosols from aqueous medicament preparations
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
EP0903151A1 (en) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
US6649602B1 (en) * 1999-11-18 2003-11-18 Alcon, Inc. Use of an H1 antagonist and a safe steroid to treat eye conditions
DE19958460A1 (de) * 1999-12-03 2001-06-07 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation
FR2803520B1 (fr) * 2000-01-12 2002-09-20 Ceva Sante Animale Procede pour augmenter la production d'oeufs et consolider la coquille des oeufs chez les volailles
US20020094345A1 (en) * 2000-10-06 2002-07-18 Sara Abelaira Pharmaceutical compositions containing epinastine and pseudoephedrine
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020151541A1 (en) * 2000-10-31 2002-10-17 Michel Pairet Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
DE10119718A1 (de) * 2001-04-21 2002-10-31 Boehringer Ingelheim Pharma Verfahren zur kontinuierlichen Herstellung inhalierfähiger Arzneistoffe, Vorrichtung zur Durchführung des Verfahrens und nach diesem Verfahren hergestellter Arzneistoff
US7420602B2 (en) * 2001-05-29 2008-09-02 Samsung Semiconductor Israel R&D Center (Sirc) Cmos imager for cellular applications and methods of using such
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
EP1350512A1 (en) * 2002-04-03 2003-10-08 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
US6863848B2 (en) * 2002-08-30 2005-03-08 Signet Armorlite, Inc. Methods for preparing composite photochromic ophthalmic lenses
JP2007145316A (ja) * 2005-10-27 2007-06-14 Nissan Motor Co Ltd 遮光装置とサンバイザーとサンルーフユニット

Also Published As

Publication number Publication date
AR026424A1 (es) 2003-02-12
BG106681A (en) 2002-12-29
HUP0203773A3 (en) 2005-01-28
HK1052303A1 (en) 2003-09-11
CA2391076C (en) 2008-06-17
EA006937B1 (ru) 2006-06-30
YU33602A (sh) 2005-03-15
PE20010826A1 (es) 2001-08-20
IL149501A0 (en) 2002-11-10
JP2003514021A (ja) 2003-04-15
US20070197503A1 (en) 2007-08-23
BG65775B1 (bg) 2009-11-30
AU784017B2 (en) 2006-01-12
NZ519425A (en) 2004-04-30
SK287343B6 (sk) 2010-07-07
TR200201270T2 (tr) 2002-12-23
PL364028A1 (en) 2004-11-29
US20090239842A1 (en) 2009-09-24
US20080009476A1 (en) 2008-01-10
HU229502B1 (en) 2014-01-28
EP1231920A1 (de) 2002-08-21
CZ302483B6 (cs) 2011-06-08
ES2281359T3 (es) 2007-10-01
DE50014041D1 (de) 2007-03-22
MY130441A (en) 2007-06-29
WO2001035962A1 (de) 2001-05-25
US20050288274A1 (en) 2005-12-29
CZ20021956A3 (cs) 2002-08-14
KR20020050273A (ko) 2002-06-26
AU2006201541A1 (en) 2006-05-11
PL198879B1 (pl) 2008-07-31
PT1231920E (pt) 2007-03-30
DE19954516A1 (de) 2001-05-17
MEP36708A (en) 2011-02-10
EP1231920B1 (de) 2007-02-07
US7429602B2 (en) 2008-09-30
RS50173B (sr) 2009-05-06
HRP20020404B1 (hr) 2007-08-31
CO5251448A1 (es) 2003-02-28
CA2391076A1 (en) 2001-05-25
DK1231920T3 (da) 2007-04-10
AU1138101A (en) 2001-05-30
EA200200492A1 (ru) 2002-10-31
US20030050303A1 (en) 2003-03-13
SK8302002A3 (en) 2002-09-10
EE200200246A (et) 2003-06-16
NO20022201L (no) 2002-05-08
NO329417B1 (no) 2010-10-18
ZA200203683B (en) 2003-09-03
NO20022201D0 (no) 2002-05-08
TWI225401B (en) 2004-12-21
UA74563C2 (uk) 2006-01-16
SA01210658B1 (ar) 2006-11-05
US20070185082A1 (en) 2007-08-09
CN1390129A (zh) 2003-01-08
HK1052303B (zh) 2007-04-13
ATE353218T1 (de) 2007-02-15
CY1106375T1 (el) 2011-10-12
HRP20020404A2 (en) 2004-08-31
HUP0203773A2 (hu) 2003-03-28
CN1292752C (zh) 2007-01-03
KR100758842B1 (ko) 2007-09-19
EE05395B1 (et) 2011-04-15
MXPA02004556A (es) 2004-09-10
IL149501A (en) 2012-04-30
SI1231920T1 (sl) 2007-06-30

Similar Documents

Publication Publication Date Title
MXPA02004556A (es) Soluciones que contienen epinastina.
BR0307267A (pt) Compostos heterocìclicos, ativos como inibidores de beta-lacta-mases
SV2002000356A (es) Nuevos derivados de piperazina ref. pc10770aixn/bb
BG66094B1 (bg) Азабициклени съединения, тяхното получаване и използване като лекарствени средста, по-специално като антибактериални средства
PA8474201A1 (es) Jarabe antihistaminico estabilizado
ECSP034436A (es) Sales de valsartan
GT199900055A (es) Nuevas dihidropirimidinas2 heterocìclicamente sustituidas.
AR031944A1 (es) Sal de fosfato del inhibidor de la oxido nitrico sintasa
BR9916111A (pt) Derivados de fenilglicina
PT96506A (pt) Processo para a preparacao de composicoes orais que incorporam como ingrediente activo pimobendano
DE60039291D1 (de) Camptothecinanaloge und deren zubereitungsmethoden
DE60104872D1 (de) Stabilisierte ophthalmische wasserstoffperoxidlösung
WO2003082855A1 (en) Anti-inflammatory agent
BR0015826A (pt) Derivados de benzotiadiazinas, seu processo de preparação e as composições farmacêuticas que os contêm
BR0210664A (pt) Processo de sìntese técnico para produção de tropenol
DOP2001000268A (es) Derivados puente de piperazina
BR0108501A (pt) Compostos de n-hidróxiformamidas substituìdos por piperidina e piperazina como agentes inibidores de metaloproteinase
BRPI0403909A (pt) Solução aquosa de tensoativos anfotéricos altamente concentrada
BR0107483A (pt) Processo para a preparação de um composto
SV2002000302A (es) Nuevos derivados de amidas heterociclicas ref. pc 10561/20140/bb
HN2000000090A (es) Sal difosfato de un derivado de 4sustituido-9-desoxo-9a-aza-9a-homoeritromicina y su composicion farmaceutica.
UY26432A1 (es) Soluciones que contienen epinastina
ES2173280T3 (es) Composiciones pulverulentas y solubles en agua y sus aplicaciones.s
BR0008031A (pt) Composição de peróxido de hidrogênio aquoso e método de retardar a taxa de decomposição de peróxido de hidrogênio
BR0112915A (pt) Composição farmacêutica compreendendo metformina e um derivado do tipo 5-fenoxialquil-2,4-tiazolidinadiona

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 13 E 10 ( VIII ) DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]